MarketWatch Automation
Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -3.19% slid 3.34% to $118.07 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -1.82% falling 2.84% to 10,737.51 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.08% falling 1.54% to 29,225.61. This was the stock's second consecutive day of losses. Moderna Inc. closed $272.53 below its 52-week high ($390.60), which the company achieved on September 30th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.12% fell 1.30% to $142.72, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.76% fell 1.11% to $228.41, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -1.38% rose 0.40% to $54.91. Trading volume (4.7 M) remained 32,345 below its 50-day average volume of 4.7 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
MRNA
Add to watchlist
DJIA
Add to watchlist
ABBV
Add to watchlist
AMGN
Add to watchlist
AZN
